Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Role of ion channels in sepsis-induced atrial tachyarrhythmias in guinea pigs.
Aoki Y, Hatakeyama N, Yamamoto S, Kinoshita H, Matsuda N, Hattori Y, Yamazaki M.
Br J Pharmacol. 2012 May;166(1):390-400. doi: 10.1111/j.1476-5381.2011.01769.x.
Related citations
Cardiac ventricular repolarization reserve: a principle for understanding drug-related proarrhythmic risk.
Varró A, Baczkó I.
Br J Pharmacol. 2011 Sep;164(1):14-36. doi: 10.1111/j.1476-5381.2011.01367.x. Review.
Pharmacological modulation of connexin-formed channels in cardiac pathophysiology.
De Vuyst E, Boengler K, Antoons G, Sipido KR, Schulz R, Leybaert L.
Br J Pharmacol. 2011 Jun;163(3):469-83. doi: 10.1111/j.1476-5381.2011.01244.x. Review.
Effects of metoprolol therapy on cardiac gap junction remodelling and conduction in human chronic atrial fibrillation.
Dhein S, Rothe S, Busch A, Rojas Gomez DM, Boldt A, Reutemann A, Seidel T, Salameh A, Pfannmüller B, Rastan A, Kostelka M, Mohr FW.
Br J Pharmacol. 2011 Sep;164(2b):607-16. doi: 10.1111/j.1476-5381.2011.01460.x.
Intrathecal orexin A increases sympathetic outflow and respiratory drive, enhances baroreflex sensitivity and blocks the somato-sympathetic reflex.
Shahid IZ, Rahman AA, Pilowsky PM.
Br J Pharmacol. 2011 Feb;162(4):961-73. doi: 10.1111/j.1476-5381.2010.01102.x.
cAMP- and Ca²(+) /calmodulin-dependent protein kinases mediate inotropic, lusitropic and arrhythmogenic effects of urocortin 2 in mouse ventricular myocytes.
Yang LZ, Kockskämper J, Khan S, Suarez J, Walther S, Doleschal B, Unterer G, Khafaga M, Mächler H, Heinzel FR, Dillmann WH, Pieske B, Spiess J.
Br J Pharmacol. 2011 Jan;162(2):544-56. doi: 10.1111/j.1476-5381.2010.01067.x.
Robust anti-arrhythmic efficacy of verapamil and flunarizine against dofetilide-induced TdP arrhythmias is based upon a shared and a different mode of action.
Oros A, Houtman MJ, Neco P, Gomez AM, Rajamani S, Oosterhoff P, Attevelt NJ, Beekman JD, van der Heyden MA, Ver Donck L, Belardinelli L, Richard S, Antoons G, Vos MA; CONTICA investigators.
Br J Pharmacol. 2010 Sep;161(1):162-75.
Possible involvement of GLP-1(9-36) in the regional haemodynamic effects of GLP-1(7-36) in conscious rats.
Gardiner SM, March JE, Kemp PA, Bennett T, Baker DJ.
Br J Pharmacol. 2010 Sep;161(1):92-102.
Selective inhibition of persistent sodium current by F 15845 prevents ischaemia-induced arrhythmias.
Pignier C, Rougier JS, Vié B, Culié C, Verscheure Y, Vacher B, Abriel H, Le Grand B.
Br J Pharmacol. 2010 Sep;161(1):79-91.
Biomarkers and endogenous determinants of dofetilide-induced torsades de pointes in α(1) -adrenoceptor-stimulated, anaesthetized rabbits.
Farkas AS, Rudas L, Makra P, Csík N, Leprán I, Forster T, Csanády M, Papp JG, Varró A, Farkas A.
Br J Pharmacol. 2010 Dec;161(7):1477-95. doi: 10.1111/j.1476-5381.2010.00965.x.
The role of nitric oxide, superoxide and peroxynitrite in the anti-arrhythmic effects of preconditioning and peroxynitrite infusion in anaesthetized dogs.
Kiss A, Juhász L, Seprényi G, Kupai K, Kaszaki J, Végh A.
Br J Pharmacol. 2010 Jul;160(5):1263-72.
Pharmacological pre- and post-conditioning with the sphingosine-1-phosphate receptor modulator FTY720 after myocardial ischaemia-reperfusion.
Hofmann U, Hu K, Walter F, Burkard N, Ertl G, Bauersachs J, Ritter O, Frantz S, Bonz A.
Br J Pharmacol. 2010 Jul;160(5):1243-51.
Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion.
Walsh SK, Hepburn CY, Kane KA, Wainwright CL.
Br J Pharmacol. 2010 Jul;160(5):1234-42.
Predicting drug-induced slowing of conduction and pro-arrhythmia: identifying the 'bad' sodium current blockers.
Lu HR, Rohrbacher J, Vlaminckx E, Van Ammel K, Yan GX, Gallacher DJ.
Br J Pharmacol. 2010 May;160(1):60-76. Epub 2010 Mar 22.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on